[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].
Identifieur interne : 000464 ( PubMed/Corpus ); précédent : 000463; suivant : 000465[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].
Auteurs : J. Zhang ; P. Peng ; X. Li ; Y F Zha ; G N Zhang ; Y. Zhang ; Y. XiangSource :
- Zhonghua fu chan ke za zhi [ 0529-567X ] ; 2020.
Abstract
Objective: To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID19. Methods: We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID19 in Renmin Hospital of Wuhan University in January 2020, and proposed management strategies for patients with gynecological tumors under risk of COVID19. Results: Three patients were treated COVID19 based on the national diagnosis and treatment protocol as well as research progress. Meanwhile, these patients were appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. Conclusions: Patients with gynecological malignant tumors are high-risk groups prone to COVID-19 infection, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.
DOI: 10.3760/cma.j.cn112141-20200302-00168
PubMed: 32174096
Links to Exploration step
pubmed:32174096Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].</title><author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Peng, P" sort="Peng, P" uniqKey="Peng P" first="P" last="Peng">P. Peng</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, X" sort="Li, X" uniqKey="Li X" first="X" last="Li">X. Li</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zha, Y F" sort="Zha, Y F" uniqKey="Zha Y" first="Y F" last="Zha">Y F Zha</name><affiliation><nlm:affiliation>Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, G N" sort="Zhang, G N" uniqKey="Zhang G" first="G N" last="Zhang">G N Zhang</name><affiliation><nlm:affiliation>Department of Gynecologic Oncology, Sichuan Cancer Hospital and Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Y" sort="Zhang, Y" uniqKey="Zhang Y" first="Y" last="Zhang">Y. Zhang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiang, Y" sort="Xiang, Y" uniqKey="Xiang Y" first="Y" last="Xiang">Y. Xiang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32174096</idno><idno type="pmid">32174096</idno><idno type="doi">10.3760/cma.j.cn112141-20200302-00168</idno><idno type="wicri:Area/PubMed/Corpus">000464</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000464</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].</title><author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Peng, P" sort="Peng, P" uniqKey="Peng P" first="P" last="Peng">P. Peng</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, X" sort="Li, X" uniqKey="Li X" first="X" last="Li">X. Li</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zha, Y F" sort="Zha, Y F" uniqKey="Zha Y" first="Y F" last="Zha">Y F Zha</name><affiliation><nlm:affiliation>Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, G N" sort="Zhang, G N" uniqKey="Zhang G" first="G N" last="Zhang">G N Zhang</name><affiliation><nlm:affiliation>Department of Gynecologic Oncology, Sichuan Cancer Hospital and Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhang, Y" sort="Zhang, Y" uniqKey="Zhang Y" first="Y" last="Zhang">Y. Zhang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiang, Y" sort="Xiang, Y" uniqKey="Xiang Y" first="Y" last="Xiang">Y. Xiang</name><affiliation><nlm:affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Zhonghua fu chan ke za zhi</title><idno type="ISSN">0529-567X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><b>Objective:</b> To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID19. <b>Methods:</b> We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID19 in Renmin Hospital of Wuhan University in January 2020, and proposed management strategies for patients with gynecological tumors under risk of COVID19. <b>Results:</b> Three patients were treated COVID19 based on the national diagnosis and treatment protocol as well as research progress. Meanwhile, these patients were appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. <b>Conclusions:</b> Patients with gynecological malignant tumors are high-risk groups prone to COVID-19 infection, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32174096</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0529-567X</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Zhonghua fu chan ke za zhi</Title><ISOAbbreviation>Zhonghua Fu Chan Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].</ArticleTitle><Pagination><MedlinePgn>E011</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112141-20200302-00168</ELocationID><Abstract><AbstractText><b>Objective:</b> To explore the management strategies for patients with gynecological malignant tumors during the outbreak and transmission of COVID19. <b>Methods:</b> We retrospectively analyzed the clinical characteristics, treatment, and disease outcomes of three patients with gynecological malignancies associated with COVID19 in Renmin Hospital of Wuhan University in January 2020, and proposed management strategies for patients with gynecological tumors under risk of COVID19. <b>Results:</b> Three patients were treated COVID19 based on the national diagnosis and treatment protocol as well as research progress. Meanwhile, these patients were appropriately adjusted the treatment plan in accordance with the clinical guidelines for gynecological tumors. Pneumonia was cured in 2 patients, and one patient died of COVID-19. <b>Conclusions:</b> Patients with gynecological malignant tumors are high-risk groups prone to COVID-19 infection, and gynecological oncologists need to carry out education, prevention, control and treatment according to specific conditions. While actively preventing and controlling COVID-19, the diagnosis and treatment of gynecological malignant tumors should be carried out in an orderly and safe manner.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Y F</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>G N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>Department of Gynecologic Oncology, Sichuan Cancer Hospital and Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Fu Chan Ke Za Zhi</MedlineTA><NlmUniqueID>16210370R</NlmUniqueID><ISSNLinking>0529-567X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>目的：</b> 在新型冠状病毒肺炎(COVID-19)暴发和传播期间，探讨妇科恶性肿瘤患者的管理策略。 <b>方法：</b> 对2020年1月武汉大学人民医院3例妇科恶性肿瘤伴发新型冠状病毒肺炎患者临床特点、处理方案和疾病转归进行回顾性分析，提出新型冠状病毒肺炎流行期间妇科恶性肿瘤患者的管理策略。 <b>结果：</b> 3例患者在按照国家颁布的COVID-19诊治方案及研究进展给予针对性治疗的前提下，依照妇科肿瘤临床指南适当调整了治疗方案，对肿瘤进行了个性化的治疗。2例患者新型冠状病毒肺炎治愈，1例患者死于新型冠状病毒肺炎。 <b>结论：</b> 妇科恶性肿瘤患者是感染COVID-19的高危人群，妇科肿瘤医师需根据具体情况做好宣教、防控及治疗等工作。在积极防控新型冠状病毒肺炎的同时，有序安全地开展妇科恶性肿瘤患者的诊治。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gynecological malignancies</Keyword><Keyword MajorTopicYN="N">Management strategy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32174096</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112141-20200302-00168</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000464 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000464 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:32174096
|texte= [Management strategies for patients with gynecological malignancies during the outbreak of COVID19].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32174096" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |